NB4-31848-55048
4 vaccinations
2 coded responses
32 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 791 / TX
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-20
-
2021-01-26
Dose 2 — Moderna
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
-
2021-02-23
Survey response — day 28, dose 2MedDRA: Headache — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-02
- 2021-03-09
- 2021-04-27
- 2021-07-27
-
2021-09-27
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-01-26
-
2022-05-17
Dose 3 — Moderna
-
2022-10-04
Dose 4 — Moderna
- 2022-10-21
- 2022-10-27
- 2022-11-01
- 2022-11-08
- 2022-11-15
-
2023-01-03
Survey response — 3 months, dose 4MedDRA: Ageusia, Anosmia, Malaise — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-03
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-04
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2022-05-17 | Moderna | No |
| 4 | 2022-10-04 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 4 — day 28, dose 2
Symptoms: Headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release